Pure Global

Efficacy and Safety of Probiotic Products for Digestive Health - Trial NCT06385639

Access comprehensive clinical trial information for NCT06385639 through Pure Global AI's free database. This phase not specified trial is sponsored by Wecare Probiotics Co., Ltd. and is currently Recruiting. The study focuses on Healthy Adult. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06385639
Recruiting
dietary supplement
Trial Details
ClinicalTrials.gov โ€ข NCT06385639
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Efficacy and Safety of Probiotic Products for Digestive Health
A Double-blind, Randomized Clinical Study, Compared With Placebo to Assess the Efficacy and Safety of a Probiotic Product Containing Four Probiotic Strains to Support Digestive Environment and Homeostasis of Gut Microbiota

Study Focus

Healthy Adult

Probiotic

Interventional

dietary supplement

Sponsor & Location

Wecare Probiotics Co., Ltd.

Jakarta, Indonesia

Timeline & Enrollment

N/A

Apr 25, 2024

Jun 25, 2024

60 participants

Primary Outcome

Intestinal health

Summary

The objective of this study is to evaluate the efficacy and safety of the probiotic product
 as an everyday gut health product in supporting digestive environment and homeostasis of gut
 microbiota.

ICD-10 Classifications

Healthy person accompanying sick person
Obesity, unspecified
Lifestyle-related condition
Adult-onset Still disease
Obesity

Data Source

ClinicalTrials.gov

NCT06385639

Non-Device Trial